Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00258271 · COMPLETED
Trial details
- NCT number
- NCT00258271
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2006-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.